Home/Filings/4/0000912282-24-000130
4//SEC Filing

LEDRU PHILIPPE 4

Accession 0000912282-24-000130

CIK 0000882361other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 5:26 PM ET

Size

5.5 KB

Accession

0000912282-24-000130

Insider Transaction Report

Form 4
Period: 2024-02-05
LEDRU PHILIPPE
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2024-02-05+11,00011,000 total
    Exercise: $2.00Exp: 2034-02-05Common Shares (11,000 underlying)
Footnotes (1)
  • [F1]50% of the options vest on February 5, 2025, with the remaining options vesting as follows: 1/3 on February 5, 2026; 1/3 on February 5, 2027; and 1/3 on February 5, 2028.

Documents

1 file

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1
  • filerCIK 0001923073

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 5:26 PM ET
Size
5.5 KB